UA

Umesh Anantha Padmanabha Bisile

Active Director Whole-Time Director DIN 02803382
DIN 02803382 First appointment Apr 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Apr 2011
Shareholding value •••• Premium profile

About Umesh Anantha Padmanabha Bisile

Data last updated:

Umesh Anantha Padmanabha Bisile is a Whole-Time Director at Invitro Research Solutions Private Limited (since 2021), Director at Biostec Data Safety Services Private Limited (since 2022) and Director at Nextbio Research Private Limited (since 2016). The companies operate in Pharma and Business Outsourcing. The 3 current companies with reported revenue have a combined latest revenue of ₹19.29 Cr; the largest is Invitro Research Solutions Private Limited at ₹19.28 Cr (FY 2023). Earlier, Umesh Anantha Padmanabha Bisile was a Director at Zumanta Pharma Private Limited (from 2011).

DIN 02803382
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 25 Apr 2011
Oldest Company Age 15 yrs
Largest company Invitro Research Solutions Private Limited · ₹19.28 Cr (FY 2023)
Combined revenue ₹19.29 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director26 Feb 20212016₹19.28 Cr (FY 2023)Active
Director18 Jul 20222022₹24,879 (FY 2025)Active
Nextbio Research Private Limited U73100KA2016PTC095455
Director02 Aug 20162016₹23,809 (FY 2022)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zumanta Pharma Private Limited U73100KA2011PTC058292
Director25 Apr 20112011₹3.5 Lakh (FY 2017)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Umesh Anantha Padmanabha Bisile

Directorship timeline

Open interactive timeline →
Zumanta Pharma Private Limited
Nextbio Research Private Limited
Biostec Data Safety Services Private Limited
Invitro Research Solutions Private Limited
Premium access

Shareholding and investment profile for Umesh Anantha Padmanabha Bisile

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umesh Anantha Padmanabha Bisile

Umesh Anantha Padmanabha Bisile currently holds 3 directorships: Invitro Research Solutions Private Limited (Whole-Time Director, since 26 Feb 2021, revenue ₹19.28 Cr (FY 2023)); Biostec Data Safety Services Private Limited (Director, since 18 Jul 2022, revenue ₹24,879 (FY 2025)); Nextbio Research Private Limited (Director, since 02 Aug 2016, revenue ₹23,809 (FY 2022)).

Umesh Anantha Padmanabha Bisile was first appointed on 25 Apr 2011 as Director at Zumanta Pharma Private Limited. The most recent appointment on record is 18 Jul 2022 at Biostec Data Safety Services Private Limited.

The 3 current companies of Umesh Anantha Padmanabha Bisile that report revenue have a combined latest revenue of ₹19.29 Cr: Invitro Research Solutions Private Limited ₹19.28 Cr (FY 2023); Biostec Data Safety Services Private Limited ₹24,879 (FY 2025); Nextbio Research Private Limited ₹23,809 (FY 2022).

Umesh Anantha Padmanabha Bisile held 1 earlier board appointment: Zumanta Pharma Private Limited (Director, from 25 Apr 2011).

The current boards of Umesh Anantha Padmanabha Bisile's companies include Subbaiah Muddanda Devaiah (Invitro Research Solutions Private Limited), Nagendra Nagasundar (Nextbio Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available